USE OF TUMOR-MARKERS IN LUNG-CANCER

被引：19

作者：

STRAUSS, GM ^{[1
]}

SKARIN, AT ^{[1
]}

机构：

[1] BRIGHAM & WOMENS HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02115

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 03期

关键词：

D O I：

10.1016/S0889-8588(18)30166-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：507 / 532

页数：26

共 133 条

[1] THYMIDINE LABELING INDEX AS PROGNOSTIC FACTOR IN RESECTED NON-SMALL CELL LUNG-CANCER [J].

ALAMA, A ;

COSTANTINI, M ;

REPETTO, L ;

CONTE, PF ;

SERRANO, J ;

NICOLIN, A ;

BARBIERI, F ;

ARDIZZONI, A ;

BRUZZI, P .

EUROPEAN JOURNAL OF CANCER, 1990, 26 (05) :622-625

[2]

ARONEY RS, 1984, CANCER TREAT REP, V68, P859

[3] The nature of the "oat-celled sarcoma" of the mediastinum. [J].

Barnard, WG .

JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1926, 29 (03) :241-244

[4] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].

BAST, RC ;

KLUG, TL ;

STJOHN, E ;

JENISON, E ;

NILOFF, JM ;

LAZARUS, H ;

BERKOWITZ, RS ;

LEAVITT, T ;

GRIFFITHS, CT ;

PARKER, L ;

ZURAWSKI, VR ;

KNAPP, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887

[5]

BATES S, 1986, ANN INTERN MED, V115, P623

[6] TUMOR-MARKERS - VALUE AND LIMITATIONS IN THE MANAGEMENT OF CANCER-PATIENTS [J].

BATES, SE ;

LONGO, DL .

CANCER TREATMENT REVIEWS, 1985, 12 (03) :163-207

[7]

BENSCH KG, 1968, CANCER, V22, P1163, DOI 10.1002/1097-0142(196811)22:6<1163::AID-CNCR2820220612>3.0.CO

[8]

2-L

[9]

BERGMAN B, 1993, EUR J CANCER, V2, P192

[10]

BERLIN NI, 1984, AM REV RESPIR DIS, V130, P545

← 1 2 3 4 5 6 7 8 9 10 →